Prenatal cannabis use was not linked to speech and language disorders, child motor delays, and other global developmental delays.

The Microbiome Therapeutics Market sector is poised for substantial growth, with a projected rise in market size by USD 974 million and a Compound Annual Growth Rate (CAGR) of 27.

Clinical Trial Application for global Phase 3 trials with nizubaglustat in GM1/GM2 gangliosidoses and Niemann-Pick Disease ...

A prospective cohort study was undertaken using a previously defined and assembled cohort. This cohort had been assembled over an 18-month interval at the Montreal Children's Hospital of the ...

antagonist enhanced efficacy as compared to either agent alone for the treatment of major depressive disorder (MDD) and other severe stress-related conditions. Columbia University, our collaboration ...

For decades, the agency, known as USAID, has been hamstrung by a procurement model that prioritizes paperwork over results, leaving America less effective and competitive in global development in ...

In 2024, Africa has taken center stage on the global development agenda, demonstrating the continent’s resilience and its deepening ties with the Global South in the international arena. From the 19th ...

“In the long run, this can lead to global societal benefits,” Chen concluded. “We hope our findings can help prioritize action for countries at all levels of development.” ...

Dec 30 (Reuters) - Sangamo Therapeutics (SGMO.O), opens new tab said on Monday that partner Pfizer (PFE.N), opens new tab has terminated their hemophilia A gene therapy co-development agreement ...